Ramos Mejía

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Type 2 diabetes3 trials
• Type 1 diabetes2 trials
• Asthma1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Liver and biliary tract cancer1 trial
• Liver cirrhosis1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Not yet recruiting3 trials
• Completed2 trials

Lead sponsor

• AstraZeneca5 trials

Running trials

• Recruiting

  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  NCT07776509· Phase 3· AstraZeneca· Source

• Recruiting

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  NCT07784270· Phase 3· AstraZeneca· Source

• Recruiting

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  NCT07784725· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Type 2 diabetes3 recruiting
• Type 1 diabetes2 recruiting

Closed trials

• Completed

  A Study in Participants With Non-cirrhotic NASH With Fibrosis

  NCT05638737· Phase 2· AstraZeneca· Source

• Completed

  Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma

  NCT05251259· Phase 2· AstraZeneca· Source